HIV :: New AIDS drugs aim to fight resistant HIV
Gilead Sciences, Inc. (Nasdaq:GILD) announced the completion of a Phase II clinical trial of GS 9137, a novel oral HIV integrase inhibitor.
Viral
Hepatitis :: Positive opinion for hepatitis B drug Sebivo
On 22 February 2007 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending to grant a marketing authorisation for the medicinal product Sebivo, 600 mg, film-coated tablet intended for treatment of chronic hepatitis B virus (HBV) infection in adult patients.
Influenza :: Pandemic influenza vaccine Focetria approved
Approval of Focetria, an immune enhancing pandemic influenza vaccine, would allow for more rapid response in the event of influenza pandemic.
Stress :: Stress measurement expert creates guide for researchers
Binghamton University Professor Gary D. James is hoping his new book will take the stress out of researching stress.
HIV :: Pay more attention to genital herpes infections in HIV-infected persons
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the Feb. 22 New England Journal of Medicine.
Genome :: 2,000 influenza virus genomes now completed and publicly accessible
The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), announced today that it has achieved a major milestone.
HIV :: Anti-herpes treatment reduces HIV levels in women infected with both viruses
Experts call for HSV control measures, including vaccine, to rank high on international HIV prevention and research agenda as exciting trial findings are published.
Pregnancy :: Experimental vaccine given during pregnancy reduces stillbirths from common virus
Researchers funded by the National Institutes of Health have developed an experimental vaccine that reduces stillbirths among rodents born to mothers infected with cytomegalovirus (CMV) — a common virus that can also cause mental retardation and hearing loss in newborn children who were infected in early fetal life.
Common Cold :: Common cold may send some young children to the hospital
New evidence supports the link between a cause of the common cold and more severe respiratory infections such as pneumonia and acute bronchitis. The study is published in the March 15 issue of The Journal of Infectious Diseases, now available online.
Gene :: RNAi shows promise in gene therapy
Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.